APA (7th ed.) Citation

S, K., R, S., L, P., B, M., & S, M. (2024). Plumbagin as a preferential lead molecule to combat EGFR-driven matrix abundance and migration of cervical carcinoma cells. Medical oncology (Northwood, London, England), 41(4), 89. https://doi.org/10.1007/s12032-024-02332-6

Chicago Style (17th ed.) Citation

S, Krishnamoorthy, Sabanayagam R, Periyasamy L, Muruganantham B, and Muthusami S. "Plumbagin as a Preferential Lead Molecule to Combat EGFR-driven Matrix Abundance and Migration of Cervical Carcinoma Cells." Medical Oncology (Northwood, London, England) 41, no. 4 (2024): 89. https://doi.org/10.1007/s12032-024-02332-6.

MLA (9th ed.) Citation

S, Krishnamoorthy, et al. "Plumbagin as a Preferential Lead Molecule to Combat EGFR-driven Matrix Abundance and Migration of Cervical Carcinoma Cells." Medical Oncology (Northwood, London, England), vol. 41, no. 4, 2024, p. 89, https://doi.org/10.1007/s12032-024-02332-6.